Management of community-acquired pneumonia

被引:0
作者
Ehsan, Mohsin [1 ]
Metersky, Mark L. [2 ,3 ]
机构
[1] St Joseph Hlth Ctr, St Charles, MO USA
[2] Univ Connecticut, Sch Med, Div Pulm & Crit Care, Farmington, CT USA
[3] Univ Connecticut, Ctr Hlth, Div Pulm & Crit Care, 263 Farmington Ave, Farmington, CT 06030 USA
关键词
Community-acquired pneumonia; Comorbidities; Biomarkers; Procalcitonin; Copeptin; Diagnosis; Antibiotic; Macrolides;
D O I
10.1007/s13665-013-0062-0
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
This article summarizes recent literature related to community-acquired pneumonia (CAP), which continues to represent one of the most common causes of morbidity and mortality throughout the world, especially in the elderly. The impact is even more striking if we take healthcare costs into account. Patients with CAP usually have other comorbidities which not only increase mortality in this group but also add further to its economic burden. Patients with COPD, preexisting cardiac disease, and diabetes are particularly at higher risk for developing more severe pneumonia. New diagnostic modalities, including ultrasonography, are being used more commonly in clinical practice. Procalcitonin levels can be used to identify bacterial pneumonia and to de-escalate antibiotic therapy, resulting in fewer days on antibiotics. Other biomarkers have been used in studies to stratify patients by risk. Guideline-concordant regimens including atypical coverage, and macrolides in particular, appear to provide benefit. More recent data suggest the need for careful screening of patients for cardiovascular risk factors prior to initiating macrolides and fluoroquinolones.
引用
收藏
页码:218 / 225
页数:8
相关论文
共 48 条
[1]  
Albrich WC, 2012, ARCH INTERN MED, V172, P715, DOI 10.1001/archinternmed.2012.770
[2]   Improving Outcomes in Elderly Patients With Community-Acquired Pneumonia by Adhering to National Guidelines Community-Acquired Pneumonia Organization International Cohort Study Results [J].
Arnold, Forest W. ;
LaJoie, A. Scott ;
Brock, Guy N. ;
Peyrani, Paula ;
Rello, Jordi ;
Menendez, Rosario ;
Lopardo, Gustavo ;
Torres, Antoni ;
Rossi, Paolo ;
Ramirez, Julio A. .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (16) :1515-1524
[3]   Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis [J].
Asadi, Leyla ;
Sligl, Wendy I. ;
Eurich, Dean T. ;
Colmers, Isabelle N. ;
Tjosvold, Lisa ;
Marrie, Thomas J. ;
Majumdar, Sumit R. .
CLINICAL INFECTIOUS DISEASES, 2012, 55 (03) :371-380
[4]   Guideline adherence and macrolides reduced mortality in outpatients with pneumonia [J].
Asadi, Leyla ;
Eurich, Dean T. ;
Gamble, John-Michael ;
Minhas-Sandhu, Jasjeet K. ;
Marrie, Thomas J. ;
Majumdar, Sumit R. .
RESPIRATORY MEDICINE, 2012, 106 (03) :451-458
[5]   Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology [J].
Bello, Salvador ;
Lasierra, Ana B. ;
Minchole, Elisa ;
Fandos, Sergio ;
Angeles Ruiz, Maria ;
Vera, Elisabeth ;
de Pablo, Francisco ;
Ferrer, Miguel ;
Menendez, Rosario ;
Torres, Antoni .
EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (05) :1144-1155
[6]  
BJERRE LM, 2009, COCHRANE DB SYST REV, V4
[7]  
Bonafede MM, 2012, AM J MANAG CARE, V18, P380
[8]   IMPACT OF PHYSICIAN-ASSISTED TRIAGE ON TIMING OF ANTIBIOTIC DELIVERY IN PATIENTS ADMITTED TO THE HOSPITAL WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) [J].
Capp, Roberta ;
Soremekun, Olan A. ;
Biddinger, Paul D. ;
White, Benjamin A. ;
Sweeney, Linda M. ;
Chang, Yuchiao ;
Brown, David F. M. .
JOURNAL OF EMERGENCY MEDICINE, 2012, 43 (03) :502-508
[9]  
Centers for Disease Control and Prevention, 2012, NAT CTR IMM RESP DIS
[10]   Cardiac Complications in Patients With Community-Acquired Pneumonia Incidence, Timing, Risk Factors, and Association With Short-Term Mortality [J].
Corrales-Medina, Vicente F. ;
Musher, Daniel M. ;
Wells, George A. ;
Chirinos, Julio A. ;
Chen, Li ;
Fine, Michael J. .
CIRCULATION, 2012, 125 (06) :773-U92